Series A Therapeutics Companies

Osmol Therapeutics develops treatment to prevent chemotherapy-induced peripheral neuropathy.

Vivatides Therapeutics develops RNA treatments to help improve patients' lives using biotechnology research.

Mytide Therapeutics is committed to providing peptides to serve a diverse array of applications.

NexCure offers clinically intense therapies in outpatient, community settings, and other cutting-edge treatments.

MDI Therapeutics is a operator of an discovery stage company focused on developing novel therapies for fibrotic diseases.

Clasp Therapeutics offers to reach of immuno-oncology with novel precision medicines that enable the immune system.

Ascend Gene & Cell Therapies is a model for gene and cell therapy manufacturing.

R1 Therapeutics is a clinical-stage biopharmaceutical company that develops first-in-class treatments for kidney disease patients.

Maxion Therapeutics helps in learning transformative therapies.

Vittude is a SaaS-enabled marketplace connecting high qualified psychologists to individuals and corporations.

NextRNA Therapeutics creates targeted therapeutics with the aim of discovering novel ncRNAs that cause disease.

Adiso Therapeutics develops medications to treat inflammatory diseases.

1859 is a biotechnology company focusing on the discovery and development of next-generation therapeutics.

Slate Medicines develops therapeutics that target Pituitary Adenylate Cyclase-Activating Polypeptide for migraine treatment and prevention.

Centauri Therapeutics is a UK-based biotechnology company focused on the discovery and development of life threatening diseases.

Perceive Pharma operates as a pharmaceutical company.

Areteia Therapeutics is a biotechnology company committed to putting asthma patients in better control of their disease.

Trotana Therapeutics is a biotech company that focuses on the discovery and development of medicines targeting RNA-binding proteins.

Faeth Therapeutics is a cancer metabolism company that focuses on nutrition treatments for cancer patients.

Expedition Therapeutics is a biotechnology company that develops novel therapies for inflammatory and respiratory diseases.

Trogenix is a biotech company that develops precision cancer treatments that selectively target diseased cell states and behaviour.

ResBiotic develops probiotic and pharmabiotic therapies to alleviate neutrophilic inflammation associated with dysbiosis.

Leal Therapeutics develops novel therapeutics for patients.

CorriXR Therapeutics is a biotechnology company.

Actithera is a molecular radiotherapeutic company that develops radioligand therapies.